Neutralizing epitopes of influenza virus hemagglutinin: target for the development of a universal vaccine against H5N1 lineages.
about
Recombinant baculovirus displayed vaccine: a novel tool for the development of a cross-protective influenza H5N1 vaccineProgress toward a universal H5N1 vaccine: a recombinant modified vaccinia virus Ankara-expressing trivalent hemagglutinin vaccine.Strategies towards universal pandemic influenza vaccines.Advances in novel influenza vaccines: a patent review.A computationally optimized broadly reactive antigen (COBRA) based H5N1 VLP vaccine elicits broadly reactive antibodies in mice and ferretsNew strategies for the development of H5N1 subtype influenza vaccines: progress and challenges.Influenza research database: an integrated bioinformatics resource for influenza research and surveillance.A computationally optimized hemagglutinin virus-like particle vaccine elicits broadly reactive antibodies that protect nonhuman primates from H5N1 infection.Development of dual-function ELISA for effective antigen and antibody detection against H7 avian influenza virus.Visualization of Alternative Functional Configurations of Influenza Virus Hemagglutinin Facilitates Rapid Selection of Complementing Vaccines in Emergency SituationsDisplay of VP1 on the surface of baculovirus and its immunogenicity against heterologous human enterovirus 71 strains in miceIdentification of a neutralizing epitope within antigenic domain 5 of glycoprotein B of human cytomegalovirus.A novel humanized antibody neutralizes H5N1 influenza virus via two different mechanismsOral Delivery of a Novel Attenuated Salmonella Vaccine Expressing Influenza A Virus Proteins Protects Mice against H5N1 and H1N1 Viral InfectionAntibody breadth and protective efficacy are increased by vaccination with computationally optimized hemagglutinin but not with polyvalent hemagglutinin-based H5N1 virus-like particle vaccines.A triclade DNA vaccine designed on the basis of a comprehensive serologic study elicits neutralizing antibody responses against all clades and subclades of highly pathogenic avian influenza H5N1 virusesMonoclonal Antibody Targeting Neutralizing Epitope on H5N1 Influenza Virus of Clade 1 and 0 for Specific H5 QuantificationInsect cell technology is a versatile and robust vaccine manufacturing platform.Update on baculovirus as an expression and/or delivery vehicle for vaccine antigens.Both the unique and repeat regions of the Porphyromonas gingivalis hemagglutin A are involved in adhesion and invasion of host cells.Genetic characterization of an H5N1 avian influenza virus from a vaccinated duck flock in Vietnam.Immune responses to baculovirus-displayed enterovirus 71 VP1 antigen.Broadening the H5N3 Vaccine Immunogenicity against H5N1 Virus by Modification of Neutralizing Epitopes.Baculovirus Surface Display of Immunogenic Proteins for Vaccine DevelopmentAvian Influenza A Virus Pandemic Preparedness and Vaccine DevelopmentComplementary recognition of the receptor-binding site of highly pathogenic H5N1 influenza viruses by two human neutralizing antibodies
P2860
Q30221529-713C0B4B-EA8C-4CB6-8886-33090E67BC46Q30366891-3539919D-446B-436C-8CE3-C357E0E7E676Q30382226-82172647-1B70-47D1-91E7-45CD36DC0A69Q30388514-D3CF13AE-F490-42D7-BB6D-245703B26BD7Q30399675-562C516F-3054-45D6-A2CF-4871D44947B1Q30407424-288F5300-3197-4ABD-BF12-3E501634F2D2Q30411991-F0F9D952-1C3D-47C6-BC2A-29CD5AC79154Q30414652-70B03220-EFFD-4EAB-A2B7-2777458B4736Q33588601-33268266-64FA-42AA-AC1E-10414BA6A687Q33624535-713FB5F9-07CE-4D08-A58C-C05BF6AF8E70Q33958090-1B1488C3-E2D4-470C-804C-50918504D789Q34992770-48E118B4-7C7B-44A1-A42F-F32D86923DF4Q35488279-6BDCAC14-DDB5-4ECD-984A-6ABC20E4C63EQ35666065-49729E7D-1D05-4F9E-9F0C-CFF68E78129CQ35739123-EB9F01B1-2B61-4AB3-AA6C-5E2E72171823Q36086664-B6456F2F-1A0F-4411-9390-B89FB48A3960Q36701950-B258B33F-96D4-4AC3-AC04-5079CA298FB7Q37909427-8C694EEE-EEB0-41BD-8C36-4896350DDBB0Q38243160-0B25F706-E795-46DC-A502-69410A6824F5Q41078585-DC146FF9-D3D9-4023-89A0-AE599301125FQ42212918-1259CD87-917F-454D-B207-4611115D001CQ43434704-1948D26A-5CAE-40A0-B2D2-ECB5EA2B3BD8Q47558838-7AA095CB-864F-4796-82EE-F403695512B5Q56514706-B979CA51-3079-40B4-8438-750F4E079FE1Q56561344-2C7EB7E4-95ED-4353-83E0-BAF85559986CQ58696897-5DA63345-5C15-4438-B1B6-3ECA14ACB10C
P2860
Neutralizing epitopes of influenza virus hemagglutinin: target for the development of a universal vaccine against H5N1 lineages.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Neutralizing epitopes of influ ...... vaccine against H5N1 lineages.
@ast
Neutralizing epitopes of influ ...... vaccine against H5N1 lineages.
@en
type
label
Neutralizing epitopes of influ ...... vaccine against H5N1 lineages.
@ast
Neutralizing epitopes of influ ...... vaccine against H5N1 lineages.
@en
prefLabel
Neutralizing epitopes of influ ...... vaccine against H5N1 lineages.
@ast
Neutralizing epitopes of influ ...... vaccine against H5N1 lineages.
@en
P2093
P2860
P356
P1433
P1476
Neutralizing epitopes of influ ...... vaccine against H5N1 lineages.
@en
P2093
Mookkan Prabakaran
Selvaraj Madhan
Tan Yunrui
P2860
P304
11822-11830
P356
10.1128/JVI.00891-10
P50
P577
2010-09-15T00:00:00Z